Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000058

Chief Medical Officer sold 20,406 shares at an average $26.61 ($542,973)

  • Chief Medical Officer acquired 14,057 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2026-03-12 Option exercise 10b5-1 +6,348 $1.08 $6,856 88,837 D
Rodman David Malcom Chief Medical Officer 2026-03-12 Sale 10b5-1 −6,348 $27.37 $173,748 82,489 D
Rodman David Malcom Chief Medical Officer 2026-03-13 Option exercise 10b5-1 +3,542 $10.20 $36,128 86,031 D
Rodman David Malcom Chief Medical Officer 2026-03-13 Option exercise 10b5-1 +4,167 $14.25 $59,380 90,198 D
Rodman David Malcom Chief Medical Officer 2026-03-13 Sale 10b5-1 −10,726 $25.91 $277,922 79,472 D
Rodman David Malcom Chief Medical Officer 2026-03-13 Sale 10b5-1 −3,079 $27.37 $84,265 76,393 D
Rodman David Malcom Chief Medical Officer 2026-03-13 Sale 10b5-1 −253 $27.82 $7,038 76,140 D
Derivatives
Rodman David Malcom Chief Medical Officer 2026-03-12 Option exercise · Stock Option 10b5-1 −6,348 25,395 D
Rodman David Malcom Chief Medical Officer 2026-03-13 Option exercise · Stock Option 10b5-1 −3,542 123,959 D
Rodman David Malcom Chief Medical Officer 2026-03-13 Option exercise · Stock Option 10b5-1 −4,167 95,834 D
Open-market sales · 20,406 sh · avg $26.61 · $542,973
Loading xslF345X05/wk-form4_1773696009.xml…